Kodiak Sciences Inc Common Stock (KOD) Financials
Key financial figures for Kodiak Sciences Inc Common Stock (Q2 2026).
Kodiak Sciences Inc. reported revenue of $0.00 for Q2 FY2026. The company posted a net loss of $65.6 million, or -$1.05 per share. Free cash flow for the period was -$46.6 million. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Kodiak Sciences Inc. are on the SentiSense financials page.
- Revenue
- $0
- Net Income
- -$66M
- EPS
- $-1.05
- Total Assets
- $257M
- Operating Cash Flow
- -$46M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $0 | -$66M | -$1.05 | -$47M | |
| Q1 FY2026 | $0 | -$58M | -$0.94 | -$41M | |
| Q4 FY2025 | $0 | -$57M | -$1.04 | -$39M | |
| Q3 FY2025 | $0 | -$61M | -$1.16 | -$33M | |
| Q2 FY2025 | $0 | -$54M | -$1.03 | -$35M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $0 | -$230M | -$4.32 | -$137M | |
| FY2024 | $0 | -$176M | -$3.35 | -$118M | |
| FY2023 | $0 | -$260M | -$4.97 | -$196M |
Frequently asked questions
What was Kodiak Sciences Inc.'s revenue last quarter?
Kodiak Sciences Inc. reported revenue of $0.00 for Q2 FY2026.
Is Kodiak Sciences Inc. profitable?
Not in its most recent reported period. Kodiak Sciences Inc. reported a net loss of $65.6 million for Q2 FY2026.
How much free cash flow did Kodiak Sciences Inc. generate?
Kodiak Sciences Inc. generated free cash flow of -$46.6 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Kodiak Sciences Inc Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.